FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4242158045> ?p ?o ?g. }

• W4242158045 endingPage "1629" @default.
• W4242158045 startingPage "1627" @default.
• W4242158045 abstract "To evaluate the published data on the association between apolipoprotein E genotype (APOE) and Alzheimer disease (AD) and determine whether the data support the use of genetic testing for diagnosis or prediction of disease. This statement is intended for neurologists, psychiatrists, geneticists, primary care providers, diagnostic laboratories, and the public.The joint American College of Medical Genetics (ACMG) and American Society of Human Genetics (ASHG) Test and Technology Transfer Committee developed a 10-member ACMG/ASHG Working Group to assess available data on the association of AD with APOE alleles. To ensure inclusion of clinical specialists primarily involved with AD patients and families, the American Academy of Neurology (AAN) and the American Psychiatric Association (APA) appointed liaisons to the Working Group.Peer-reviewed journal publications obtained from an Index Medicus search or known to members of the Working Group were the source of data on which the statement is based.Following discussions with all members of the Working Group, a draft statement was prepared by the chair and circulated among all members until a consensus was reached. The consensus draft was sequentially reviewed and endorsed by the appropriate scientific and executive committees of the ACMG, ASHG, AAN, APA, and the National Institutes of Health-Department of Education Working Group on Ethical, Legal, and Social Implications of Human Genome Research. In some instances, suggestions from these committees were incorporated into the final statement.There is general consensus that APOE epsilon 4 is strongly associated with AD and that when present may represent an important risk factor for the disease. However, at the present time it is not recommended for use in routine clinical diagnosis nor should it be used for predictive testing. Studies to date indicate that the APOE genotype alone does not provide sufficient sensitivity or specificity to allow genotyping to be used as a diagnostic test. Because AD develops in the absence of APOE epsilon 4 and because many with APOE epsilon 4 seem to escape disease, genotyping is also not recommended for use as a predictive genetic test. The results of a collaborative study under way will clarify some of these issues. Whether APOE genotypes have other uses in the management of AD will become apparent over the next few years." @default.
• W4242158045 created "2022-05-12" @default.
• W4242158045 date "1995-11-22" @default.
• W4242158045 modified "2023-10-13" @default.
• W4242158045 title "Statement on use of apolipoprotein E testing for Alzheimer disease. American College of Medical Genetics/American Society of Human Genetics Working Group on ApoE and Alzheimer disease" @default.
• W4242158045 doi "https://doi.org/10.1001/jama.274.20.1627" @default.
• W4242158045 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/7474250" @default.
• W4242158045 hasPublicationYear "1995" @default.
• W4242158045 type Work @default.
• W4242158045 citedByCount "80" @default.
• W4242158045 countsByYear W42421580452012 @default.
• W4242158045 countsByYear W42421580452013 @default.
• W4242158045 countsByYear W42421580452014 @default.
• W4242158045 countsByYear W42421580452015 @default.
• W4242158045 countsByYear W42421580452016 @default.
• W4242158045 countsByYear W42421580452017 @default.
• W4242158045 countsByYear W42421580452018 @default.
• W4242158045 countsByYear W42421580452019 @default.
• W4242158045 countsByYear W42421580452021 @default.
• W4242158045 crossrefType "journal-article" @default.
• W4242158045 hasConcept C104317684 @default.
• W4242158045 hasConcept C142724271 @default.
• W4242158045 hasConcept C2779134260 @default.
• W4242158045 hasConcept C512399662 @default.
• W4242158045 hasConcept C54355233 @default.
• W4242158045 hasConcept C57089818 @default.
• W4242158045 hasConcept C64474127 @default.
• W4242158045 hasConcept C71924100 @default.
• W4242158045 hasConcept C74909509 @default.
• W4242158045 hasConcept C86803240 @default.
• W4242158045 hasConceptScore W4242158045C104317684 @default.
• W4242158045 hasConceptScore W4242158045C142724271 @default.
• W4242158045 hasConceptScore W4242158045C2779134260 @default.
• W4242158045 hasConceptScore W4242158045C512399662 @default.
• W4242158045 hasConceptScore W4242158045C54355233 @default.
• W4242158045 hasConceptScore W4242158045C57089818 @default.
• W4242158045 hasConceptScore W4242158045C64474127 @default.
• W4242158045 hasConceptScore W4242158045C71924100 @default.
• W4242158045 hasConceptScore W4242158045C74909509 @default.
• W4242158045 hasConceptScore W4242158045C86803240 @default.
• W4242158045 hasIssue "20" @default.
• W4242158045 hasLocation W42421580451 @default.
• W4242158045 hasLocation W42421580452 @default.
• W4242158045 hasOpenAccess W4242158045 @default.
• W4242158045 hasPrimaryLocation W42421580451 @default.
• W4242158045 hasRelatedWork W2000191171 @default.
• W4242158045 hasRelatedWork W2019171079 @default.
• W4242158045 hasRelatedWork W2046366626 @default.
• W4242158045 hasRelatedWork W2082482010 @default.
• W4242158045 hasRelatedWork W2087109004 @default.
• W4242158045 hasRelatedWork W2117839560 @default.
• W4242158045 hasRelatedWork W2129836373 @default.
• W4242158045 hasRelatedWork W2135309334 @default.
• W4242158045 hasRelatedWork W2407880944 @default.
• W4242158045 hasRelatedWork W2903851525 @default.
• W4242158045 hasVolume "274" @default.
• W4242158045 isParatext "false" @default.
• W4242158045 isRetracted "false" @default.
• W4242158045 workType "article" @default.